Growth Metrics

GeneDx Holdings (WGS) Non-Current Deferred Tax Liability (2021 - 2025)

GeneDx Holdings (WGS) has disclosed Non-Current Deferred Tax Liability for 4 consecutive years, with $1.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 1.99% to $1.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.0 million, a 1.99% decrease, with the full-year FY2024 number at $965000.0, down 38.14% from a year prior.
  • Non-Current Deferred Tax Liability was $1.0 million for Q3 2025 at GeneDx Holdings, up from $747000.0 in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $2.7 million in Q2 2022 to a low of $747000.0 in Q2 2025.
  • A 4-year average of $1.7 million and a median of $1.5 million in 2023 define the central range for Non-Current Deferred Tax Liability.
  • Peak YoY movement for Non-Current Deferred Tax Liability: plummeted 48.83% in 2024, then dropped 1.99% in 2025.
  • GeneDx Holdings' Non-Current Deferred Tax Liability stood at $2.7 million in 2022, then crashed by 41.33% to $1.6 million in 2023, then plummeted by 38.14% to $965000.0 in 2024, then grew by 7.05% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for WGS's Non-Current Deferred Tax Liability are $1.0 million (Q3 2025), $747000.0 (Q2 2025), and $1.2 million (Q1 2025).